QUOTIENT DIAGNOSTICS LTD.
Quotient Diagnostics Ltd. develops a testing technology for the diagnosis, treatment, and management of diabetes and associated diseases.
QUOTIENT DIAGNOSTICS LTD.
Industry:
Biotechnology Health Care Information Technology
Founded:
2002-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Status:
Active
Contact:
44 1932 220124
Similar Organizations
Chemogen
Chemogen's proprietary and patented technology for the diagnosis of tuberculosis (TB) in immunocompromised people marks a new chapter.
Fast Biotechnologies
Fast Biotechnologies developing a revolutionary method for highly- sensitive and fast detection of microorganisms.
Heartbit
Heartbit is developing a portable tool for the diagnosis and monitoring of new-generation cardiovascular diseases.
Microsens
Microsens Diagnostics (MD) was established to exploit an established technology and patent portfolio in the field of diagnostics.
Veridentia
Veridentia is a pioneering technology company that researches, develops, manufactures and markets a unique and patented Blood Transfusion
More informations about "Quotient Diagnostics Ltd."
Quotient Diagnostics Ltd. - Crunchbase Company Profile & Funding
Organization. Quotient Diagnostics Ltd. Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. Quotient Diagnostics Ltd. develops a testing technology for …See details»
Home | Quotient - AliveDx
Quotient and FAS Diagnostic Group, Inc. sign distribution agreement in the Philippines Quotient and FAS Diagnostic Group, Inc. have signed a distribution agreement, which will enable FAS …See details»
Quotient Diagnostics Company Profile 2024: Valuation, Investors ...
Quotient Diagnostics General Information Description. Developer of immunohematology products. The company develops testing technologies for the diagnosis and treatment of diabetes and …See details»
AABB | Quotient - AliveDx
In this role, we support the organization’s mission of, “improving lives by making transfusion medicine and biotherapies safe, available, and effective worldwide. ... Evaluation of the …See details»
AliveDx: Pioneering Faster Disease Detection and …
Our Commercial and Strategy group works across our organization, with customers and other external partners to achieve our corporate mission: Transforming Transfusion Diagnostics and Beyond. The group is responsible …See details»
Quotient Limited - AnnualReports.com
Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is …See details»
Quotient Diagnostics Ltd. - Crunchbase
Quotient Diagnostics Ltd. develops a testing technology for the diagnosis, treatment, and management of diabetes and associated diseases.See details»
Quotient Diagnostics Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore Quotient Diagnostics Ltd. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial.See details»
Quotient Evolves into AliveDx: Pioneers in Faster …
Jul 25, 2023 Not only must we support life, but help people to live better. Our mission is to empower diagnostic insights, transform patient care, and innovate for life. Our products, Alba and MosaiQ, have already demonstrated valuable …See details»
Quotient Diagnostics Ltd - SelectScience
Quotient Diagnostics Ltd Quotient Diagnostics is a company with a novel patented assay technology to address the diagnosis, treatment and management of diabetes and associated …See details»
Quotient Biodiagnostics - Crunchbase Company Profile & Funding
Quotient Biodiagnostics is focused on providing high quality, high value immunohematology products to hospitals and blood banks in the US. Through its wholly-owned subsidiary, Alba …See details»
TTP plc collaborates with Quotient Ltd to transform transfusion ...
Cambridge, UK, 20 May 2019: TTP plc (TTP), a leading independent technology and product development company, has announced today that it has partnered with Quotient Ltd …See details»
AliveDX Diagnostics: Creating Value for Stakeholders
JERSEY, Channel Islands, September 8th 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient), headquartered in …See details»
Quotient Limited Selected to Join the World Economic Forum
Sep 8, 2022 “At Quotient, we believe access to safe blood is a human right—and innovation in blood security, clinical diagnostics, hemovigilance and transfusion medicine keeps people …See details»
Quotient Limited and Theradiag Announce Partnership to Advance ...
Jun 8, 2022 Regulatory News: THERADIAG (ISIN: FR0004197747, Mnemonic: ALTER) (Paris:ALTER), a company specializing in in vitro diagnostics and theranostics, todaySee details»
Quotient Limited Provides Business Update and Delays Releasing …
Nov 8, 2021 JERSEY, Channel Islands, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the …See details»
Quotient Limited Announces Appointment of Chief Financial
Oct 12, 2021 JERSEY, Channel Islands, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced Ali …See details»
Quotient's MosaiQ IH Microarray Receives CE Mark for Enhanced …
Mar 8, 2022 About Quotient Limited Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering …See details»
Blood Transfusion Test Company Quotient Files for Bankruptcy
Jan 10, 2023 Quotient Ltd., a publicly traded blood transfusion diagnostics company, filed for Chapter 11 bankruptcy in Texas on Tuesday. The company reported assets of about $128 …See details»